Repeated low-level red-light therapy

Specsavers has launched low-level light therapy (LLLT) alongside intense pulsed light (IPL) as part of a major rollout of advanced...

The rise of standalone dry eye clinics is no longer a fringe movement. Insight speaks to the people behind Australian...

Recent conferences have offered fresh clinical insights into repeated low-level red-light (RLRL) therapy in myopia management. At this year’s Asia-Pacific...

Repeated low-level red-light (RLRL) therapy has been included in the 2025 Myopia Consensus Statement released by the World Society of...

The first Australian data into the efficacy of repeated low-level red-light (RLRL) has been published in what is shaping to...

The inventor of the Eyerising International repeated low-level red light (RLRL) therapy for myopia, Professor Mingguang He, has outlined “notable...

At the completion of this article, the reader should be able to discuss RLRL with their myopia patients,  including: Understand...

Repeated low-level red-light (RLRL) device manufacturer Eyerising International says the reclassification of the emerging myopia management intervention in China is...

  Australian medical device company Eyerising International says its device has been “misrepresented” in a recent study over the safety...

Eyerising International has addressed questions over the safety of its repeated-low level red-Light (RLRL) treatment for myopia management, following two...